Trials / Completed
CompletedNCT02551497
Study to Evaluate the Interaction Between a Drug and CNV1014802 in Healthy Subjects
Double-Blind, Randomised, Placebo-Controlled, Parallel Group Study to Evaluate the Interaction Between a Drug and CNV1014802 in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 36 (actual)
- Sponsor
- Biogen · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
This is a double-blind, randomised, placebo-controlled 3 period study to evaluate the interaction between a drug and CNV1014802 in healthy male and female subjects. It is planned to enrol 36 subjects.
Detailed description
This study was previously posted by Convergence Pharmaceuticals, Ltd., which has been acquired by Biogen.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | CNV1014802 |
Timeline
- Start date
- 2015-04-30
- Primary completion
- 2016-08-16
- Completion
- 2016-08-26
- First posted
- 2015-09-16
- Last updated
- 2017-10-16
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT02551497. Inclusion in this directory is not an endorsement.